Cargando…

Prognostic indices of inflammatory markers, cognitive function and fatigue for survival in patients with localised colorectal cancer

BACKGROUND: Inflammation promotes the development of malignancy, while a variety of systemic markers of inflammation predict for worse cancer outcomes including recurrence and survival. Here, we evaluate the prognostic impact of cytokine concentrations, full blood count (FBC) differential ratios, co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vardy, Janette L, Dhillon, Haryana Mary, Pond, Gregory R, Renton, Corrinne, Clarke, Stephen J, Tannock, Ian F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844380/ https://www.ncbi.nlm.nih.gov/pubmed/29531839 http://dx.doi.org/10.1136/esmoopen-2017-000302

Ejemplares similares

Lack of cognitive impairment in long-term survivors of colorectal cancer
por: Vardy, Janette L., et al.
Publicado: (2022)

A randomised controlled trial evaluating two cognitive rehabilitation approaches for cancer survivors with perceived cognitive impairment
por: Vardy, Janette L., et al.
Publicado: (2022)

The impact of physical activity on fatigue and quality of life in lung cancer patients: a randomised controlled trial protocol
por: Dhillon, Haryana M, et al.
Publicado: (2012)

On the receiving end: have patient perceptions of the side-effects of cancer chemotherapy changed since the twentieth century?
por: Vardy, Janette L., et al.
Publicado: (2022)

Health status and needs of cancer survivors attending the Sydney Survivorship Centre clinics and programmes: a protocol for longitudinal evaluation of the centre’s services
por: Vardy, Janette L, et al.
Publicado: (2017)

Is there a need for change in cancer survivorship care? A qualitative exploration of survivor experiences and needs at the Sydney Cancer Survivorship Centre Clinic
por: Obeid, Liam Anthony, et al.
Publicado: (2023)

Screening for cognitive symptoms among cancer patients during chemotherapy: Sensitivity and specificity of a single item self‐report cognitive change score
por: Fardell, Joanna E., et al.
Publicado: (2022)

Dying of mesothelioma: A qualitative exploration of caregiver experiences
por: Lee, Jessica T., et al.
Publicado: (2022)

How long is too long? A scoping review of health system delays in lung cancer
por: Malalasekera, Ashanya, et al.
Publicado: (2018)

Symptom Clusters in Survivorship and Their Impact on Ability to Work among Cancer Survivors
por: Fardell, Joanna E., et al.
Publicado: (2023)

Low dose aspirin blocks breast cancer-induced cognitive impairment in mice
por: Walker, Adam K., et al.
Publicado: (2018)

Neurocognitive Function and Quality of Life Outcomes in the ONTRAC Study for Skin Cancer Chemoprevention by Nicotinamide
por: Martin, Andrew J., et al.
Publicado: (2019)

Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy
por: Vardy, J, et al.
Publicado: (2006)

Analytical approaches and estimands to take account of missing patient-reported data in longitudinal studies
por: Bell, Melanie L, et al.
Publicado: (2019)

Investigation of herb-drug interactions with ginkgo biloba in women receiving hormonal treatment for early breast cancer
por: Vardy, Janette, et al.
Publicado: (2013)

A review of the content and psychometric properties of cancer-related fatigue (CRF) measures used to assess fatigue in intervention studies
por: Campbell, Rachel, et al.
Publicado: (2022)

An Autonomous Wearable System for Predicting and Detecting Localised Muscle Fatigue
por: Al-Mulla, Mohamed R., et al.
Publicado: (2011)

Whole brain radiotherapy after local treatment of brain metastases in melanoma patients - a randomised phase III trial
por: Fogarty, Gerald, et al.
Publicado: (2011)

Longitudinal exploration of cancer-related cognitive impairment in patients with newly diagnosed aggressive lymphoma: protocol for a feasibility study
por: Gates, Priscilla, et al.
Publicado: (2020)

Prognostic value of pretreatment inflammatory markers in localised prostate cancer before radical prostatectomy
por: Grogg, Josias Bastian, et al.
Publicado: (2023)

Age as an independent prognostic factor for survival of localised synovial sarcoma patients
por: Vlenterie, Myrella, et al.
Publicado: (2015)

Expression of Interleukin-8, Interleukin-10 and Epstein-Barr Viral-Load as Prognostic Indicator in Nasopharyngeal Carcinoma
por: Savitri, Eka, et al.
Publicado: (2015)

Magnetic marker localisation in breast cancer surgery
por: Žatecký, Jan, et al.
Publicado: (2020)

A Review of Non-Invasive Techniques to Detect and Predict Localised Muscle Fatigue
por: Al-Mulla, Mohamed R., et al.
Publicado: (2011)

Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials
por: Vardy, Janette, et al.
Publicado: (2009)

Cancer-related cognitive impairment in patients with newly diagnosed aggressive lymphoma undergoing standard chemotherapy: a longitudinal feasibility study
por: Gates, Priscilla, et al.
Publicado: (2022)

Migration of a nodule localisation marker to the contralateral lung
por: Skondras, Evangelos, et al.
Publicado: (2021)

Prognostic markers for colorectal cancer
por: Tyrrell, Helen E.J., et al.
Publicado: (2018)

OsMTP11 is localised at the Golgi and contributes to Mn tolerance
por: Farthing, Emily C., et al.
Publicado: (2017)

“POLAR-izing” Findings From Trials of Neuroprotection for Oxaliplatin Neuropathy
por: Teng, Christina, et al.
Publicado: (2022)

Editorial: Psychosocial Advances in Neuro-Oncology
por: Ownsworth, Tamara, et al.
Publicado: (2015)

The detection of delirium in admitted oncology patients: a scoping review
por: Sands, Megan B., et al.
Publicado: (2022)

Two Cases of Localised Necrosis of the Lung, with Recovery
por: Clarke, J. Michell
Publicado: (1902)

Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer
por: Chua, W, et al.
Publicado: (2009)

Prognostic Value of CD1B in Localised Prostate Cancer
por: Lee, Cheng-Hsueh, et al.
Publicado: (2019)

Natural history and prognostic factors for localised small bowel adenocarcinoma
por: Colina, Andreina, et al.
Publicado: (2020)

Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer
por: Bertorelle, R, et al.
Publicado: (2013)

Fatigue-free operation of most body-powered prostheses not feasible for majority of users with trans-radial deficiency
por: Hichert, Mona, et al.
Publicado: (2017)

First interim analysis of a randomised trial of whole brain radiotherapy in melanoma brain metastases confirms high data quality
por: Fogarty, Gerald B, et al.
Publicado: (2015)

Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes
por: Stintzing, Sebastian, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_htj53rvg1pt6d50sb1kb8laqco